Home › Compare › GLIN vs JNJ

GLIN vs JNJ: Dividend Comparison 2026

GLIN yields 0.98% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GLIN wins by $1.0K in total portfolio value
10 years
GLIN
GLIN
● Live price
0.98%
Share price
$39.62
Annual div
$0.39
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.1K
Annual income
$104.48
Full GLIN calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — GLIN vs JNJ

📍 GLIN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGLINJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GLIN + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
GLIN pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GLIN
Annual income on $10K today (after 15% tax)
$83.33/yr
After 10yr DRIP, annual income (after tax)
$88.81/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $614.81/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GLIN + JNJ for your $10,000?

GLIN: 50%JNJ: 50%
100% JNJ50/50100% GLIN
Portfolio after 10yr
$20.5K
Annual income
$466.13/yr
Blended yield
2.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GLIN
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GLIN buys
0
JNJ buys
0
No recent congressional trades found for GLIN or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGLINJNJ
Forward yield0.98%3.36% ✓
Annual dividend / share$0.39$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$21.1K ✓$20.0K
Annual income after 10y$104.48$827.78 ✓
Total dividends collected$1.0K$5.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GLIN vs JNJ ($10,000, DRIP)

YearGLIN PortfolioGLIN Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,798$98.04$10,676$355.77+$122.00 → GLIN
2$11,653$98.94$11,407$389.39+$246.00 → GLIN
3$12,568$99.78$12,198$426.53+$370.00 → GLIN
4$13,549$100.58$13,056$467.62+$493.00 → GLIN
5$14,598$101.33$13,987$513.12+$611.00 → GLIN
6$15,722$102.04$14,998$563.56+$724.00 → GLIN
7$16,926$102.71$16,098$619.52+$828.00 → GLIN
8$18,214$103.34$17,295$681.69+$919.00 → GLIN
9$19,593$103.93$18,599$750.82+$994.00 → GLIN
10$21,069$104.48$20,022$827.78+$1.0K → GLIN

GLIN vs JNJ: Complete Analysis 2026

GLIN — Stock

VanEck India Growth Leaders ETF (GLIN) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MarketGrader India All-Cap Growth Leaders Index (MGINGRNR), which consists of fundamentally sound Indian companies that exhibit attractive growth potential at a reasonable price.

Full GLIN Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this GLIN vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GLIN vs SCHDGLIN vs JEPIGLIN vs OGLIN vs KOGLIN vs MAINGLIN vs ABBVGLIN vs MRKGLIN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.